Please assess the completion status of the following clinical trial:

Trial Title: OSA Screen Negative With Spinal Duramorph

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* OSA screen negative per hospital protocol~* age 18 or greater~* BMI\>35~* consent to participate to wear capnography and pulse oximetry monitoring devices post delivery~Exclusion Criteria:~* Spanish speaking only~* under age 18~* contraindication to receiving drugs utilized in delivery anesthetic

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- capnography monitoring (Type: OTHER): single arm, all subjects receiving duramorph will receive capnography monitoring

Based on this trial design, predict the completion outcome and termination type (if applicable).